The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Screening for Cervical Cancer With High-Risk Human Papillomavirus Testing: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force
Open accessAbstract
Importance: Cervical cancer can be prevented with detection and treatment of precancerous cell changes caused primarily by high-risk types of human papillomavirus (hrHPV), the causative agents in more than 90% of cervical cancers. Objective: To systematically review benefits and harms of cervical cancer screening for hrHPV to inform the US Preventive Services Task Force. Data Sources: MEDLINE, PubMed, PsycINFO, and the Cochrane Collaboration Registry of Controlled Trials from January 2011 through February 15, 2017; surveillance through May 25, 2018. Study Selection: Randomized clinical trials (RCTs) and cohort studies comparing primary hrHPV screening alone or hrHPV cotesting (both hrHPV testing and cytology) with cytology (Papanicolaou [Pap] test) screening alone. Data Extraction and Synthesis: Two investigators independently reviewed abstracts and full-text articles and quality rated included studies; data were qualitatively synthesized. Main Outcomes and Measures: Invasive cervical cancer; cervical intraepithelial neoplasia (CIN); false-positive, colposcopy, and biopsy rates; psychological harms. Results: Eight RCTs (n = 410 556), 5 cohort studies (n = 402 615), and 1 individual participant data (IPD) meta-analysis (n = 176 464) were included. Trials were heterogeneous for screening interval, number of rounds, and protocol. For primary hrHPV screening, evidence was consistent across 4 trials demonstrating increased detection of CIN 3 or worse (CIN 3+) in round 1 (relative risk [RR] range, 1.61 [95% CI, 1.09-2.37] to 7.46 [95% CI, 1.02-54.66]). Among 4 hrHPV cotesting trials, first-round CIN 3+ detection was not significantly different between screening groups; RRs for cumulative CIN 3+ detection over 2 screening rounds ranged from 0.91 to 1.13. In first-round screening, false-positive rates for primary hrHPV screening ranged from 6.6% to 7.4%, compared with 2.6% to 6.5% for cytology. For cotesting, false-positives ranged from 5.8% to 19.9% in the first round of screening, compared with 2.6% to 10.9% for cytology. First-round colposcopy rates were also higher, ranging 1.2% to 7.9% for primary hrHPV testing, compared with 1.1% to 3.1% for cytology alone; colposcopy rates for cotesting ranged from 6.8% to 10.9%, compared with 3.3% to 5.2% for cytology alone. The IPD meta-analysis of data from 4 cotesting trials and 1 primary hrHPV screening trial found lower risk of invasive cervical cancer with any hrHPV screening compared with cytology alone (pooled RR, 0.60 [95% CI, 0.40-0.89]). Conclusions and Relevance: Primary hrHPV screening detected higher rates of CIN 3+ at first-round screening compared with cytology. Cotesting trials did not show initial increased CIN 3+ detection. Both hrHPV screening strategies had higher false-positive and colposcopy rates than cytology, which could lead to more treatments with potential harms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Church, J. A. (2001) · Journal of Government Information · doi:10.1016/s1352-0237(01)00307-0 · Cited by 9,153
The causal relation between human papillomavirus and cervical cancer
Bosch, F. X., Lorincz, A., Munoz, N., Meijer, C. J. L. M., & Shah, K. V. (2002) · Journal of Clinical Pathology · doi:10.1136/jcp.55.4.244 · Cited by 3,538
Human papillomavirus and cervical cancer
Schiffman, M., Castle, P. E., Jeronimo, J., Rodriguez, A. C., & Wacholder, S. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61416-0 · Cited by 2,985
Ronco, G., Dillner, J., Elfström, K. M., Tunesi, S., Snijders, P. J. F., Arbyn, M., Kitchener, H., Segnan, N., Gilham, C., Giorgi-Rossi, P., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62218-7 · Cited by 1,810
Current methods of the U.S. Preventive Services Task Force
Harris, R. P., Helfand, M., Woolf, S. H., Lohr, K. N., Mulrow, C. D., Teutsch, S. M., & Atkins, D. (2001) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(01)00261-6 · Cited by 1,731
Global Burden of Human Papillomavirus and Related Diseases
Forman, D., de Martel, C., Lacey, C. J., Soerjomataram, I., Lortet-Tieulent, J., Bruni, L., Vignat, J., Ferlay, J., Bray, F., Plummer, M., et al. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.07.055 · Cited by 1,642
Prevalence of HPV Infection Among Females in the United States
Dunne, E. F., Unger, E. R., Sternberg, M., McQuillan, G., Swan, D. C., Patel, S. S., & Markowitz, L. E. (2007) · JAMA · doi:10.1001/jama.297.8.813 · Cited by 1,579
McCredie, M. R., Sharples, K. J., Paul, C., Baranyai, J., Medley, G., Jones, R. W., & Skegg, D. C. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70103-7 · Cited by 1,123
Screening for cervical cancer: U.S. preventive services Task force recommendation statement
Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-12-201206190-00424 · Cited by 1,049
Ronco, G., Giorgi-Rossi, P., Carozzi, F., Confortini, M., Palma, P. D., Del Mistro, A., Ghiringhello, B., Girlando, S., Gillio-Tos, A., De Marco, L., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70360-2 · Cited by 936
Human Papillomavirus and Papanicolaou Tests to Screen for Cervical Cancer
Naucler, P., Ryd, W., Törnberg, S., Strand, A., Wadell, G., Elfgren, K., Rådberg, T., Strander, B., Johansson, B., Forslund, O., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa073204 · Cited by 797
International Journal of Cancer
(2006) · International Journal of Cancer · doi:10.1002/(issn)1097-0215 · Cited by 665
Katki, H. A., Kinney, W. K., Fetterman, B., Lorey, T., Poitras, N. E., Cheung, L., Demuth, F., Schiffman, M., Wacholder, S., & Castle, P. E. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70145-0 · Cited by 570
Rijkaart, D. C., Berkhof, J., Rozendaal, L., van Kemenade, F. J., Bulkmans, N. W., Heideman, D. A., Kenter, G. G., Cuzick, J., Snijders, P. J., & Meijer, C. J. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70296-0 · Cited by 515
Singh, G. K., Williams, S. D., Siahpush, M., & Mulhollen, A. (2011) · Journal of Cancer Epidemiology · doi:10.1155/2011/107497 · Cited by 464
Surgery for cervical intraepithelial neoplasia
Martin-Hirsch, P. P., Paraskevaidis, E., Bryant, A., & Dickinson, H. O. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001318.pub3 · Cited by 415
Kitchener, H. C., Almonte, M., Thomson, C., Wheeler, P., Sargent, A., Stoykova, B., Gilham, C., Baysson, H., Roberts, C., Dowie, R., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70156-1 · Cited by 388
Ronco, G., Segnan, N., Giorgi-Rossi, P., Zappa, M., Casadei, G. P., Carozzi, F., Palma, P. D., Del Mistro, A., Folicaldi, S., Gillio-Tos, A., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj209 · Cited by 313
Ronco, G., Giorgi-Rossi, P., Carozzi, F., Confortini, M., Palma, P. D., Del Mistro, A., Gillio-Tos, A., Minucci, D., Naldoni, C., Rizzolo, R., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn065 · Cited by 306
Ogilvie, G. S., van Niekerk, D., Krajden, M., Smith, L. W., Cook, D., Gondara, L., Ceballos, K., Quinlan, D., Lee, M., Martin, R. E., et al. (2018) · JAMA · doi:10.1001/jama.2018.7464 · Cited by 279
Bulkmans, N. W. J., Rozendaal, L., Snijders, P. J. F., Voorhorst, F. J., Boeke, A. J. P., Zandwijken, G. R. J., van Kemenade, F. J., Verheijen, R. H. M., v Groningen, K., Boon, M. E., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.20076 · Cited by 269
Snijders, P. J. F., Verhoef, V. M. J., Arbyn, M., Ogilvie, G., Minozzi, S., Banzi, R., van Kemenade, F. J., Heideman, D. A. M., & Meijer, C. J. L. M. (2013) · International Journal of Cancer · doi:10.1002/ijc.27790 · Cited by 265
Gage, J. C., Schiffman, M., Katki, H. A., Castle, P. E., Fetterman, B., Wentzensen, N., Poitras, N. E., Lorey, T., Cheung, L. C., & Kinney, W. K. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju153 · Cited by 258
Racey, C. S., Withrow, D. R., & Gesink, D. (2013) · Canadian Journal of Public Health · doi:10.1007/bf03405681 · Cited by 232
Ronco, G., Giorgi-Rossi, P., Carozzi, F., Dalla Palma, P., Del Mistro, A., De Marco, L., De Lillo, M., Naldoni, C., Pierotti, P., Rizzolo, R., et al. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70731-8 · Cited by 225
Katki, H. A., Schiffman, M., Castle, P. E., Fetterman, B., Poitras, N. E., Lorey, T., Cheung, L. C., Raine-Bennett, T., Gage, J. C., & Kinney, W. K. (2013) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0b013e318285423c · Cited by 212
McCaffery, K., Waller, J., Forrest, S., Cadman, L., Szarewski, A., & Wardle, J. (2004) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2004.00279.x · Cited by 203
Vital signs: cervical cancer incidence, mortality, and screening - United States, 2007-2012.
Benard, V. B., Thomas, C. C., King, J., Massetti, G. M., Doria-Rose, V. P., & Saraiya, M. (2014) · PubMed Central · Cited by 196
ARTISTIC: a randomised trial of human papillomavirus (HPV) testing in primary cervical screening
Kitchener, H., Almonte, M., Gilham, C., Dowie, R., Stoykova, B., Sargent, A., Roberts, C., Desai, M., & Peto (2009) · Health Technology Assessment · doi:10.3310/hta13510 · Cited by 186
Ziegert, C., Wentzensen, N., Vinokurova, S., Kisseljov, F., Einenkel, J., Hoeckel, M., & von Knebel Doeberitz, M. (2003) · Oncogene · doi:10.1038/sj.onc.1206629 · Cited by 167
Rositch, A. F., Nowak, R. G., & Gravitt, P. E. (2014) · Cancer · doi:10.1002/cncr.28548 · Cited by 161
Kitchener, H. C., Canfell, K., Gilham, C., Sargent, A., Roberts, C., Desai, M., & Peto, J. (2014) · Health Technology Assessment · doi:10.3310/hta18230 · Cited by 159
Elfstrom, K. M., Smelov, V., Johansson, A. L. V., Eklund, C., Naucler, P., Arnheim-Dahlstrom, L., & Dillner, J. (2014) · BMJ · doi:10.1136/bmj.g130 · Cited by 142
Vesco, K. K., Whitlock, E. P., Eder, M. L., Burda, B. U., Senger, C. A., & Lutz, K. W. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-10-201111150-00377 · Cited by 138
Self-citationDijkstra, M. G., van Zummeren, M., Rozendaal, L., van Kemenade, F. J., Helmerhorst, T. J. M., Snijders, P. J. F., Meijer, C. J. L. M., & Berkhof, J. H. (2016) · BMJ · doi:10.1136/bmj.i4924 · Cited by 137
Surgery for cervical intraepithelial neoplasia
Martin‐Hirsch, P. L., Paraskevaidis, E. A., Bryant, A., Dickinson, H. O., & Keep, S. L. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001318.pub2 · Cited by 135
Treatment outcomes for squamous intraepithelial lesions
Nuovo, J., Melnikow, J. A., Willan, A. R., & Chan, B. K. S. (1999) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(99)00162-9 · Cited by 116
Self-citationLeinonen, M. K., Nieminen, P., Lönnberg, S., Malila, N. K., Hakama, M., Pokhrel, A., Laurila, P., Tarkkanen, J., & Anttila, A. (2012) · BMJ · doi:10.1136/bmj.e7789 · Cited by 115
Canfell, K., Caruana, M., Gebski, V., Darlington-Brown, J., Heley, S., Brotherton, J. M. L., Gertig, D. M., Jennett, C. J., Farnsworth, A., Tan, J., et al. (2017) · PLoS Medicine · doi:10.1371/journal.pmed.1002388 · Cited by 106
Conner, S. N., Frey, H. A., Cahill, A. G., Macones, G. A., Colditz, G. A., & Tuuli, M. G. (2014) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000000174 · Cited by 103
Ogilvie, G. S., Krajden, M., van Niekerk, D., Smith, L. W., Cook, D., Ceballos, K., Lee, M., Gentile, L., Gondara, L., Elwood‐Martin, R., et al. (2017) · International Journal of Cancer · doi:10.1002/ijc.30454 · Cited by 101
Ogilvie, G. S., van Niekerk, D. J., Krajden, M., Martin, R. E., Ehlen, T. G., Ceballos, K. M., Peacock, S. J., Smith, L., Kan, L., Cook, D. A., et al. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-111 · Cited by 93
Kyrgiou, M., Mitra, A., Arbyn, M., Paraskevaidi, M., Athanasiou, A., Martin‐Hirsch, P. L., Bennett, P. R., & Paraskevaidis, E. A. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008478.pub2 · Cited by 92
Five-Year Risks of CIN 3+ and Cervical Cancer Among WomenWho Test Pap-Negative But Are HPV-Positive
Katki, H. A., SCHIFFMAN, M. H., Castle, P. E., Fetterman, B. J., Poitras, N. E., Lorey, T. S., Cheung, L. C., Raine‐Bennett, T. R., Gage, J. C., & Kinney, W. (2013) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0b013e318285437b · Cited by 92
Castle, P. E., Kinney, W., Xue, X., Cheung, L. C., Gage, J. C., Zhao, F., Fetterman, B. J., Poitras, N. E., Lorey, T. S., Wentzensen, N., et al. (2017) · Annals of Internal Medicine · doi:10.7326/m17-1609 · Cited by 77
(2017) · The SHAFR Guide Online · doi:10.1163/2468-1733_shafr_sim010030021 · Cited by 77
Partridge, E. E., Abu‐Rustum, N. R., Campos, S. M., Fahey, P. J., Farmer, M. R., Garcia, R. L., Giuliano, A. R., Jones, H. W., Lele, S. M., Lieberman, R. W., et al. (2010) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2010.0103 · Cited by 73
Demarco, M., Lorey, T. S., Fetterman, B. J., Cheung, L. C., Guido, R. S., Wentzensen, N., Kinney, W., Poitras, N. E., Befano, B., Castle, P. E., et al. (2017) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0000000000000343 · Cited by 70
Kitchener, H. C., Fletcher, I. J., Roberts, C., Wheeler, P., Almonte, M., & Maguire, P. (2007) · International Journal of Gynecological Cancer · doi:10.1111/j.1525-1438.2007.01113.x · Cited by 67
Huynh, J., Howard, M., & Lytwyn, A. (2010) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0b013e3181dc115b · Cited by 64
Gage, J. C., Katki, H. A., SCHIFFMAN, M. H., Fetterman, B. J., Poitras, N. E., Lorey, T. S., Cheung, L. C., Castle, P. E., & Kinney, W. (2014) · International Journal of Cancer · doi:10.1002/ijc.29143 · Cited by 60
Cook, D. A., Mei, W., Smith, L., van Niekerk, D. J., Ceballos, K. M., Franco, E. L., Coldman, A. J., Ogilvie, G. S., & Krajden, M. (2015) · BMC Cancer · doi:10.1186/s12885-015-1959-5 · Cited by 55
Luyten, A., Buttmann‐Schweiger, N., Luyten, K., Mauritz, C., Reinecke‐Lüthge, A., Pietralla, M., Meijer, C. J. L. M., & Petry, K. U. (2014) · International Journal of Cancer · doi:10.1002/ijc.28783 · Cited by 49
Partridge, E. E., Abu‐Rustum, N. R., Giuliano, A. R., Massad, S. L., McClure, J. S., Dwyer, M. A., & Hughes, M. (2014) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2014.0035 · Cited by 40
Petry, K. U., Luyten, A., & Scherbring, S. (2012) · Gynecologic Oncology · doi:10.1016/j.ygyno.2012.10.017 · Cited by 34
Vesco, K. K., Whitlock, E. P., Eder, M. L., Lin, J. S., Burda, B. U., Senger, C. A., Holmes, R. S., Fu, R. F., & Zuber, S. P. (2017) · Cited by 29
Self-citationGage, J. C., Hunt, W. C., SCHIFFMAN, M. H., Katki, H. A., Cheung, L. C., Myers, O., Cuzick, J. M., Wentzensen, N., Kinney, W., Castle, P. E., et al. (2016) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000001721 · Cited by 29
Protecting the underscreened women in developed countries: the value of HPV test
Ibáñez, R., Autonell, J., Sardà, M., Crespo, N., Pique, P., Pascual, A. G., Martí, C. D., Fibla, M., Gutiérrez, C., Lloveras, B., et al. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-574 · Cited by 26
Zorzi, M., Frayle, H., Rizzi, M., Fedato, C., Rugge, M., Penon, M. G., Bertazzo, A., Callegaro, S., Campagnolo, M., Ortu, F., et al. (2017) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.14575 · Cited by 21
Variable Risk of Cervical Precancer and Cancer After a Human Papillomavirus–Positive Test
Castle, P. E., Fetterman, B. J., Poitras, N. E., et al. (2011) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e318209da59 · Cited by 17
Coldman, A. J., Gondara, L., Smith, L., van Niekerk, D., Ceballos, K. M., Krajden, M., Cook, D. A., Quinlan, D. J., Lee, M. H., Stuart, G. C. E., et al. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.368 · Cited by 15
The Ethics of Research on Pregnant Women: Is Maternal Consent Sufficient?
Lupton, M. G. F., & Williams, D. J. (2004) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/bjo.2004.111.issue-12 · Cited by 5
Cited by
Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement
US Preventive Services Task Force, Curry, S. J., Krist, A. H., Owens, D. K., Barry, M. J., Caughey, A. B., Davidson, K. W., Doubeni, C. A., Epling, J. W., Kemper, A. R., et al. (2018) · JAMA · doi:10.1001/jama.2018.10897 · Cited by 1,409
Fontham, E. T. H., Wolf, A. M. D., Church, T. R., Etzioni, R., Flowers, C. R., Herzig, A., Guerra, C. E., Oeffinger, K. C., Shih, Y. T., Walter, L. C., et al. (2020) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21628 · Cited by 968
Smith, R. A., Andrews, K. S., Brooks, D., Fedewa, S. A., Manassaram‐Baptiste, D., Saslow, D., & Wender, R. C. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21557 · Cited by 701
Circulating tumor DNA and liquid biopsy in oncology
Cescon, D. W., Bratman, S. V., Chan, S. M., & Siu, L. L. (2020) · Nature Cancer · doi:10.1038/s43018-020-0043-5 · Cited by 600
Miller, J. M., Binnicker, M. J., Campbell, S., Carroll, K. C., Chapin, K. C., Gonzalez, M. D., Harrington, A., Jerris, R. C., Kehl, S. C., Leal, S. M., et al. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciae104 · Cited by 376
Metadata
- Authors
- Melnikow, J., Henderson, J. T., Burda, B. U., Senger, C. A., Durbin, S., & Weyrich, M. S.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2018-08-21
- Volume
- 320
- Issue
- 7
- Pages
- 687
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2888052930
- Cited by
- 302
- References
- 62
- FWCI
- 22.33
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.